Hospice CFOs are fielding more technology requests than they used to, and the budget hasn't grown at the same pace. Clinical teams want tools that reduce administrative burden. Operations wants systems that make multi-location reporting less painful. IT wants to retire aging point solutions. Every request sounds reasonable in isolation, which is exactly the problem: reasonable isn't the same as ready to fund.
What actually separates a funded initiative from a deferred one is whether the person making the request can answer a simple question with a number instead of an adjective: what specifically changes, and how would we know it worked?
This dynamic isn't unique to hospice, but it's sharper here because the budget itself is more constrained. Under a fixed per-diem Medicare benefit, there's no revenue line that grows simply because the organization spent more on technology. Every dollar allocated to one initiative is explicitly a dollar not allocated to another, which is exactly why the business case has to do more work than it might in an industry with more budget flexibility.
A technology request that competes well for budget usually has four characteristics.
It's also worth naming what doesn't help a proposal's chances, even though it often gets included anyway: comparisons to what competitors are doing, general industry benchmarks without a source, or urgency framed around a deadline rather than a measured outcome. None of these give a CFO anything to hold the investment accountable to six months after approval, which is ultimately what determines whether a similar request gets easier or harder to fund next cycle.
Rather than evaluating every technology request on its own terms, CFOs get more consistent decisions by asking each proposal the same set of questions:
The reason BetterRX's business case is straightforward to build is that its outcomes are already measured and tied to specific numbers rather than general claims. Per BetterRX's Voice of the Customer survey across six consecutive years, 86% of clients report reduced medication service failures, with 41% reporting failures “significantly decreased.” That's a concrete before-and-after claim a CFO can put directly into a budget request. On nurse time, BetterRX's 2026 Voice of Customer Survey Results show 5–6 hours saved per nurse per week.
BetterRX Guardrails™ and real-time reporting move cost visibility from a monthly report into the ordering workflow itself, which lets finance teams make proactive decisions using today's data, not last month's reports. A PPD Performance Dashboard and 30+ reports put the pharmacy spend analysis finance teams would otherwise build in spreadsheets inside the platform. And because BetterRX is one standardized platform that scales from 1 to 100+ locations without multiplying complexity, the same business case can carry from one site to the next. Transparent, pass-through pricing matters here too: BetterRX does not profit from medication or delivery markups, so its incentives stay aligned with the hospice's. For the transition, BetterRX provides dedicated onboarding from kickoff through go-live, with implementation coordinated across teams and locations.
The technology requests that win funding aren't necessarily the most sophisticated ones. They're the ones that make it easy for a CFO to say yes, because the outcome, the baseline, and the scalability are already spelled out. That matters because a champion's enthusiasm doesn't transfer to the people who didn't sit through the demo; the case has to stand on the finance outcomes alone. Before bringing a technology request to the budget conversation, it's worth writing the one-sentence version first: “This investment moves [specific metric] from [current number] to [projected number], and it works the same way at every location we operate.” If that sentence can't be written honestly, the proposal isn't ready for budget season yet.
Consider two proposals competing for the same budget cycle. The first asks for funding to "improve pharmacy efficiency," citing general industry trends and a vendor's marketing claims. The second states that current medication service failures run at a specific baseline rate, that the proposed platform publishes sourced customer data showing reduced medication service failures, and that the same investment will apply without modification at every location the organization operates today or adds in the next two years.
The second proposal wins more often, not because it's more expensive or more sophisticated, but because it gives the CFO something concrete to hold the initiative accountable to after the money is spent.
Winning approval is only the first half of a strong technology business case. What happens in the months afterward often determines whether a similar request gets easier or harder to fund next cycle.